Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome - No Study Results Posted

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (DAPPER)

This study is enrolling participants by invitation only.

Study NCT01511978 Information provided by Jacobus Pharmaceutical

First Received: December 24, 2011 Last Updated: April 30, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)